Despite a previous history of experiencing hemiplegic migraines once or twice a year, the patient reported daily occurrences of migraines, many of which were hemiplegic, during the 60 days of GLP-1 agonist treatment
Retatrutide, a new weight loss drug from Eli Lilly, shows promising results in clinical trials, but its not yet available
Thermogenic effects of commercially available plant preparations aimed at treating human obesity
In Australia, several GLP1 medications are registered on the Australian Register of Therapeutic Goods (ARTG) and available by prescription through an AHPRA-registered doctor
PlexusDx recommends tracking your appetite, mood, energy, and any side effects daily so you and your provider can identify patterns and optimize dosing adjustments
LC-MS/MS spectra of semaglutide in the blank (left) and LLOQ (0.4 ng/mL) (right) samples Figure 6